Haw Par Corporation Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other
pharmaceutical manufacturers in Asia:
sales of 11.04 billion Indian Rupees [US$169.90 million]
Koei Chemical Company, Limited
(17.28 billion Japanese Yen [US$162.94 million]
Indoco Remedies Ltd
based in India
(10.93 billion Indian Rupees [US$168.23 million]
of which 100%
Haw Par Corporation Limited reported sales of 222.76 million Singapore Dollars (US$169.02 million)
December of 2017.
increase of 10.5%
versus 2016, when the company's sales were 201.64 million Singapore Dollars.
Sales at Haw Par Corporation Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 60%).